CRDF
Cardiff Oncology Inc
1.20$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.5% | 95.7% | 88.6% | 77.1% | 90.1% | 86.8% | 99.0% | 97.7% | 95.8% | 94.8% | 97.8% | 97.2% | |
| 94.5% | 94.5% | 86.2% | 67.0% | 80.8% | 77.9% | 97.2% | 8.0% | 14.1% | 26.5% | 53.0% | 28.2% | |
| 94.5% | 94.5% | 86.2% | 67.0% | 80.8% | 77.9% | 97.2% | 94.2% | 90.6% | 91.7% | 94.4% | 94.2% | |
| 0.2% | 0.1% | 0.2% | 0.6% | 1.2% | 1.6% | 0.2% | 0.4% | 0.7% | 0.4% | 0.8% | 0.3% | |
| -1.5% | 0.0% | – | 0.0% | – | 0.0% | – | – | – | – | – | – | |
| 2.9% | 3.8% | 8.7% | 19.8% | 9.2% | 6.7% | 0.5% | 0.3% | 1.1% | – | – | – | |
| 71.1% | 31.8% | 55.0% | 47.0% | 28.8% | 44.1% | 4.9% | 6.1% | 8.5% | 14.6% | 14.7% | 26.7% | |
| 15.5% | 11.5% | 17.7% | 32.1% | 20.9% | 36.5% | 4.5% | 4.4% | 6.7% | 12.8% | 13.8% | 26.5% | |
| 6.6% | 7.3% | 5.4% | 10.8% | – | 6.6% | 0.6% | 0.4% | 0.6% | 0.8% | 0.7% | 1.2% | |
| 9.0% | 1.5% | 2.6% | 6.7% | 4.7% | 5.0% | 1.0% | 1.0% | 1.7% | 2.4% | 5.0% | 13.1% | |
| – | 15.7% | 32.3% | – | – | – | – | – | – | – | – | – | |
| 28.9% | 68.2% | 45.0% | 53.0% | 71.2% | 55.9% | 95.1% | 93.9% | 91.5% | 85.4% | 85.3% | 73.3% | |
| -281.7% | -152.4% | -337.0% | -1,408.6% | -1,356.1% | -1,596.3% | -171.8% | -173.7% | -256.6% | -415.9% | -395.3% | -694.9% | |
| 0.9% | 0.5% | 1.0% | 3.9% | 16.4% | 45.6% | 15.5% | 26.1% | 37.5% | 54.7% | 49.0% | 108.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.